In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

On The Move (Company Changes and Promotions 06/11)

Executive Summary

Recent executive-level company changes and promotions in the biotech, pharmaceutical, and medical device industries.

ANDERES, Kenna, PhD

To:Molecular Response LLC, SVP, Translational Medicine (May)

From:Cylene Pharmaceuticals Inc., VP, Cancer Biology

Tel:858-622-2900

ARNOLD, Lyle, PhD

To:Biocept Inc., SVP, CSO (May)

From:Aegea Biotechnologies Inc., Founder & Director

Tel:858-320-8200

BECK, Douglas

To:iBio Inc., CFO (May)

From:Lev Pharmaceuticals Inc., CFO

Tel:302-355-0650

BENDER, Norbert, MD, PhD

To:Evolva SA, CMO (May)

From:Medical Consultant

Tel:+41 61 485 2000

BONFIGLIO, John N., PhD

To:Oragenics Inc., Pres. & CEO (May)

From:Transdel Phamaceuticals Inc., Pres. & CEO

Tel:386-418-4018

BUTITTA, Cynthia

To:NextWave Pharmaceuticals Inc., SVP, CFO (May)

From:Telik Inc., COO & CFO

Tel:408-342-1300

CALVARESE, Barry

To:PreCision Dermatology Inc., EVP, R&D, & CTO (May)

From:Dow Pharmaceutical Sciences Inc., VP, Clinical & Regulatory Affairs

Tel:888-713-8154

CZEREPAK, Elizabeth A.

To:Cancer Genetics Inc., CFO (May)

From:Bear, Sterns & Co., Managing Dir.

Tel:201-528-9200

DUNN, Michael

To:Biocept Inc., SVP, Corp. Dev. (May)

From:Consultant

Tel:858-320-8200

ECK, Stephen, MD, PhD

To:Astellas Pharma Global Development Inc., VP, Head, Medicinal Oncology (May)

From:Eli Lilly & Co., VP, Translational Medicine & Pharmacogenomics

Tel:800-695-4321

EISENBUD, David E., MD

To:CoDa Therapeutics Inc., CMO (May)

From:Overlook Hospital Wound Healing Program, Medical Dir.

Tel:858-677-0474

ELIZONDO, David R.

To:Direct Flow Medical Inc., Chief Dev. Officer (May)

From:ATS Medical Inc., VP, R&D, & General Mgr., Tissue Valve Ops.

Tel:707-576-0420

FORBES-MCKEAN, Kimberley, PhD

To:Aqua Pharmaceuticals LLC, VP, R&D (May)

From:Cutanea Life Sciences Inc., EVP, CSO

Tel:610-644-7000

FORD, Rodger

To:MicroMed Cardiovascular Inc., Chmn. & CEO (May)

From:SynCardia Systems Inc., Pres. & CEO

Tel:713-839-9210

GARMEY, Edward, MD

To:Cerulean Pharma Inc., SVP, CMO (May)

From:ArQule Inc., VP, Clinical Dev.

Tel:617-551-9600

GLASSELL, Claes

To:CMS Biologics Inc., CEO (May)

From:Cerus Corp., CEO

Tel:425-485-1900

HALLER, Michael F., PhD

To:Anaphore Inc., SVP, Strategic Parternships (May)

From:Halozyme Therapeutics Inc., VP, Alliance Mgmt. & Portfolio Dev.

Tel:858-587-4815

ISHRAK, Omar, PhD

To:Medtronic Inc., Chmn. & CEO (June)

From:GE Healthcare Systems, Pres. & CEO

Tel:763-514-4000

JOHNSON, James A.

To:Relypsa Inc., SVP, CFO (May)

From:ZymoGenetics Inc., EVP, CFO

Tel:408-200-9500

JOHNSTON, Thomas

To:Mucosis BV, CBO (May)

From:Novavax Inc., VP, Strategy

Tel:+31 50 82000 50

JONES, Richard

To:Shield Therapeutics AG, CFO (May)

From:Brewin Dolphin Investment Banking, Dir. & Head, Healthcare

Tel:+44 1932 268436

KENNY, Kevin J.

To:Cardiovascular Systems Inc., EVP, Sales & Mktg. (May)

From:Medtronic Inc., Exec. Consultant, Special Projects, Medtronic Spine & Biologics

Tel:877-274-0360

LOGAN, H. Casey

To:Anaphore Inc., SVP, Bus. Dev. (May)

From:Anadys Pharmaceuticals Inc., Senior Dir., Head, Corp. Dev.

Tel:858-587-4815

LYTTON, Michael

To:Patheon Inc., EVP, Corp. Dev. & Strategy, & General Counsel (May)

From:Biogen Idec Inc., EVP, Corp. & Bus. Dev.

Tel:919-226-3200

MACKAY, Keith

To:BioLeap LLC, VP, Sales (May)

From:GVK Biosciencs Inc., VP, Sales & Mktg.

Tel:215-371-2874

MAPES, Harold C.

To:Delcath Systems Inc., EVP, Global Operations (May)

From:AngioDynamics Inc., SVP, Operations

Tel:212-489-2100

MARTIN, David C., PhD

To:Novadaq Technologies Inc., VP, Bus. Dev. & Investor Relations (May)

From:Dundee Securities, Healthcare Analyst

Tel:905-629-3822

MARTIN, Kip

To:Columbia Laboratories Inc., VP, Bus. Dev. (May)

From:Consultant

Tel:866-566-5636

MCCARTHY, Shawn P.

To:Tryton Medical Inc., Pres. & CEO (May)

From:AngioDynamics Inc., SVP, General Mgr., Vascular & Oncology Surgery

Tel:919-226-1490

MCREYNOLDS, Cristopher

To:Alverix Inc., VP, Bus. Dev. (May)

From:Satoris Inc., CEO

Tel:408-432-8372

MULLEN, Michael J.

To:Rapid Microbiosystems Inc., CFO (May)

From:Valeritas Inc., Interim CFO

Tel:781-271-1444

MURPHY, Robert J.

To:NuPathe Inc., VP, Sales (May)

From:Pfizer Inc., SVP, Hospital & Surgical Products

Tel:484-567-0130

PANGRATZ, Christian M.

To:Activaero GMBH, CBO (May)

From:Nektar Therapeutics Inc., Exec. Dir., Bus. Dev.

Tel:+49 6453 648180

PARSLEY, Ed

To:Aires Pharmaceuticals Inc., CMO (May)

From:Pfizer Inc., Clinical Lead, Revatio

Tel:858-366-9670

PELLINI, Michael J., MD

To:Foundation Medicine Inc., Pres. & CEO (May)

From:Clarient Inc., Pres. & COO

Tel:617-418-2200

RAUTSOLA, Riku, PhD

To:Laurantis Pharma Oy, Pres. & CEO (May)

From:Virxsys Corp., Pres. & CEO

Tel:+358 2 4788 378

REEVES, Karen, MD

To:Astellas Pharma Gobal Development Inc., VP, Global Head, Medicinal Science (May)

From:Medivation Inc., SVP, Clinical Dev.

Tel:800-695-4321

RUIZ, Nancy, MD

To:Optimer Pharmaceuticals Inc., SVP, R&D (May)

From:Merck Research Laboratories, VP, Project & Pipeline Mgmt., Infectious Diseases

Tel:858-909-0736

SCHWALM, Cynthia

To:Optimer Pharmaceuticals Inc., SVP, International (May)

From:Eisai Pharmaceuticals Inc., Pres.

Tel:858-909-0736

SHORES, Clyde W.

To:Cytori Therapeutics Inc., EVP, Mktg. & Sales (May)

From:Baxter International Inc., VP, Global Mktg., Renal

Tel:858-458-0900

SORENSEN, Gregory, MD

To:Siemens Healthcare US, CEO (June)

From:Massachusetts General Hospital, Co-director, Martinos Center for Biomedical Imaging

Tel:610-408-0121

TULLMAN, Steve

To:Yaupon Therapeutics Inc., Chmn. & CEO (May)

From:Vicept Therapeutics Inc., Chmn.

Tel:610-975-9290

VERNIMB, Jeff

To:Insight Pharmaceuticals Corp., VP, Sales (May)

From:Dynova Laboratories, VP, Mktg. & Sales

Tel:267-852-0505

WATSON, Andy

To:RainDance Technologies Inc., VP, Chief Mktg. Officer (May)

From:Life Technologies Corp., VP, SOLiD Sequencing Product Mgmt.

Tel:781-861-6300

WAYNE, Jeff

To:PreCision Dermatology Inc., VP, General Mgr., Onset Dermatologics (May)

From:Promius Pharma LLC, SVP, Sales & Mktg.

Tel:888-713-8154

WOLF, Rob

To:Angeion Corp., CFO (May)

From:Rimage Corp., CFO

Tel:612-315-2000

ZEIHER, Bernhardt, MD

To:Astellas Pharma Global Development Inc., VP, Therapeutic Area Leader, Inflammation, Immunology, & Infectious Diseases (May)

From:Pfizer Inc., VP, Inflammation/Immunology Therapeutic Area

Tel:800-695-4321

Promotions

BRAGA, Damian A.

To:Sanofi Pasteur

New Title:SVP, Commercial Operations, Vaccines (May)

Previous Title:Pres., Sanofi Pasteur US & VP, Sanofi Pasteur Americas

Tel:570-839-7187

BEHRS, Melissa Kelly

To:Geron Corp.

New Title:SVP, Strategic Portfolio Mgmt. (May)

Previous Title:VP, Corp. Dev. & SVP, Therapeutic Dev., Oncology

Tel:650-473-7700

GARIPPA, Michael

To:SynCardia Systems Inc.

New Title:Pres. & CEO (May)

Previous Title:Pres.

Tel:520-545-1234

GENTILE, Tom

To:GE Healthcare

New Title:Pres. & CEO, Healthcare Systems (May)

Previous Title:GE Aviation, VP, Services

Tel:800-345-2700

HANGAUER, David, PhD

To:Kinex Pharmaceuticals LLC

New Title:CSO (May)

Previous Title:SVP, Research

Tel:716-881-8972

HARRINGTON, Stephanie A. S.

To:Frantz Medical Group

New Title:COO (May)

Previous Title:VP, Research & Bus. Dev.

Tel:440-255-1155

KELSEY, Stephen, MD

To:Geron Corp.

New Title:EVP, Head, R&D, & CMO (May)

Previous Title:EVP, CMO, Oncology

Tel:650-473-7700

LAU, Johnson, MD, PhD

To:Kinex Pharmaceuticals LLC

New Title:CEO (May)

Previous Title:Chmn.

Tel:716-881-8972

LINGELBACH, Thomas

To:Intercell AG

New Title:CEO (May)

Previous Title:COO

Tel:+43 120620

SAYER, Kevin

To:DexCom Inc.

New Title:Pres. (June)

Previous Title:Chmn., Audit Committee

Tel:858-200-0200

SWINFORD, Michael J.

To:GE Healthcare

New Title:Pres. & CEO, Global Services (May)

Previous Title:General Mgr., Americas Services

Tel:800-345-2700

WANTANABE, Karl

To:Olympus Corp. of the Americas

New Title:Pres., Corporate (May)

Previous Title:EVP, CFO

Tel:484-896-5000

WOODFORD, Michael C.

To:Olympus Corp. of the Americas

New Title:Chmn. & CEO (May)

Previous Title:Pres. & COO

Tel:484-896-5000

Resignations

ARKOWITZ, David

From:AMAG Pharmaceuticals Inc., EVP, CFO & CBO (June)

Tel:617-498-3300

COOPER, Fred W.

From:Usana Health Sciences Inc., Pres. & COO (May)

Tel:801-954-7100

FIROUZ, Fereydoun

From:EMD Serono Inc., Pres. & CEO (May)

Tel:781-982-9000

LINDGREN, Fredrik

From:Karo Bio AB, CEO (May)

Tel:+46 86 08 6000

SMITH, Philip I.

From:Angeion Corp., CEO (May)

Tel:612-315-2000

WILSON, Mark H.

From:Usana Health Sciences Inc., EVP, Sales (May)

Tel:801-954-7100

WINSTEAD, Dwight

From:CareFusion Corp., COO (June)

Tel:858-617-2000

YATES, Jeffrey A.

From:Usana Health Sciences Inc., CFO (May)

Tel:801-954-7100

Latest Headlines
See All
UsernamePublicRestriction

Register

IV003662

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel